Cooperman Leon G’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
Other funds holding KALV
Cooperman Leon G's KALV Position: Q1 2016 in Review
Cooperman Leon G sold out of KalVista Pharmaceuticals (KALV) in Q1 2016, closing a stake of 6,971 shares — an estimated $353K sold.
Cooperman Leon G first reported a position in KALV in Q2 2015 and held it in 3 quarters. The position peaked at $715K in Q2 2015. 32 funds tracked by Wall St. Rank hold KALV as of Q1 2016.
- Cooperman Leon G reported no remaining KalVista Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
- Cooperman Leon G sold 6,971 KalVista Pharmaceuticals shares in Q1 2016, an estimated $353K.
- Cooperman Leon G first reported a position in KalVista Pharmaceuticals in Q2 2015 and held it in 3 quarters.
- Cooperman Leon G's KalVista Pharmaceuticals position peaked at $715K in Q2 2015.
- 32 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q1 2016.
Based on Cooperman Leon G's 13F filing for Q1 2016, filed 16 May 2016.